DLT Resolution Inc. (DLTI)

[Stephimac]

Are you all aware of the Ultroid recall? Apparently this is the effort to complete the FDA approval. Hard to get updates from Ultroid and how they are going to move forward.

[Stephimac]

Does anyone know how to contact George Cao? Where is there business??

[asdfu099]

Ultroid is nothing but a virtual company operated out of JASWINDER SINGH 's home. Obviously this breaks the chain of control / custody of sterile products. From what I understand Singh a former handy-man construction person turned Ultroid customer service representative was quickly promoted to Vice President to enable Michael Cao to keep his name oft the Recall press release. I don't think this will protect Mr. Cao as he signed agreements and letters and he his been running the show of Ultroid and even Hemcare as we now know. Incidentally Mr. Singh also was Cao's nominee shareholder. Seems like Cao is a professional when it comes to using fall guys. Even his own family!

Of course with the criminal investigation and Micheal Knox being charged, Knox had to step down as President.

Wonder when Cao(s) will go down next?

[asdfu099]

Michael Knoxx hides his shares under his wife's name. Karen Knox.

Michael and James Cao hides shares under HIEU Cao and Peter Cao.

[asdfu099]

FDA Investigation and Criminal Charges laid....

Michael Knox charged and Michael Cao is under investigation and about to, or perhaps already has been charged.

I told you this was corrupt!

http://www.prweb.com/releases/2016/09/prweb13713481.htm

[asdfu099]

FDA Investigation and Criminal Charges laid....

Michael Knox charged and Michael Cao is under investigation and about to, or perhaps already has been charged.

I told you this was corrupt!

http://www.prweb.com/releases/2016/09/prweb13713481.htm

[Stephimac]

My understanding is Ultroid is moving forward with their business model. Medical clearance takes lots of time...RN

[skipsvalue]

New CEO maybe something will finally get done.

[Jiffen]

Can I confirm this information elsewhere? Your comments are less favorable than I have heard elsewhere. As an Ultroid investor I am concerned.

[Stephimac]

This is all really scary stuff. I'm going to make some calls this week and find out more about this. Thanks for the heads up on the.

[pennyscams1]

They also put out press on buying 95%of Dr. Delgado's practice a year later and nothing. The Cao's are major scamers

[pennyscams1]

What ever happen to the sale of Ultroid and why are they late on the quarterly report it seems that they are always late. It's not like they have anything new to report

[asdfu099]

BEWARE OF MICHAEL CAO He has been pumping and touting Ultroid for 10 years, claiming how great his technology is yet all he does is swindle money out of unsuspecting investors. DO YOUR research on him and his brother James Cao before investing in any of his schemes. Typically he creates divisions of Ultroid that actually own nothing and then sells shares of the companies to people. Yet none of the companies create sales or returns. Of course the money raised is spent on them selves and the global travelling they are always unto. There will be no money or assets in the company is you try going after them. Ask investors and former executives of Ultroid Technology and Vascular Technologies

Be very careful with these slippery brothers..

Michael Khoa Cao age 55 ([e-mail])

From: Allen, TX
737 Lauren Way,Allen, TX 75002 [phone] [e-mail]
Previous Addresses: 708 Jean Edias St, Abbeville, LA 70510,
5051 Michoud Blvd, New Orleans, LA 70129,
5128 Revel St, New Orleans, LA 70129,
11903 Newbrook Dr, Houston, TX 77072,
13603 Nemours St, New Orleans, LA 70129,
29001 PO Box, New Orleans, LA 70189,
140 PO Box, Phoenixville, PA 19453
Possible Relatives: Khanh Kim Cao,
Khuong Marc Cao,
Kim K Cao,
Charlie Cao,
Ve Tran Cao,
Tuan Thanh Cao,
Xuyen Vancao,
Francis Khang Cao,
Vu Vuong Cao
Other Phone Numbers: [phone],
[phone],
[phone],
[phone],
[phone],
[phone],
[phone]

[asdfu099]

f you want to know where all the stock went, why the PR's announcing clinic's to be open and MOU's to acquire companies all failed and why he fails to disclose to shareholders how bad things are. Or why he feels SEC Rules and Regulations are beneath him and his doesn't have to bother with them feel free to ask him. I sure wouldn't use this scammer as my real estate agent!

James Hai Cao (age 52) lives at 6668 83Rd Ave Pinellas Park, FL

[asdfu099]

Looks like James Cao and his brother Michael Cao have been keeping busy. This is not good news for HCRE:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124886671

[asdfu099]

I have read your links on the various companies however I cannot see...

"Little more then that though. Trahan was CEO of MSE Enviro-Tech Corp and did a 5 million dollar business deal with himself and made the shareholders pay for it.

Can you help me understand how Trahan did a deal with "himself" and how and where "the "shareholders paid for it"?

Thanks in advance!

[ATCrunch]

Little more then that though. Trahan was CEO of MSE Enviro-Tech Corp and did a 5 million dollar business deal with himself and made the shareholders pay for it.

http://www.mseenviro-tech.com/contact.html
In November 2009, MSE Enviro-Tech Corp ("MSE") assigned to the Company the rights to sell MSE's fire retardant products in the United States. In consideration for the assignment of these rights, the Company issued MSE a promissory note in the principal amount of $5,000,000.

In November 2009, Gilles Trahan and Martin Baldwin were appointed directors of the Company. Subsequent to these appointments, Ms. Barnum and Mr. Barnum resigned as officers and directors of the Company. Mr. Trahan was then appointed as the Company's President and Chief Executive Officer and Mr. Baldwin was appointed as the Company's Secretary, Treasurer and Chief Financial Officer.

Here they do a deal with Great rock Dev which was formerly called grid cloud solutions.

On January 27, 2011, the Company changed its name to Bio-Carbon Solutions International, Inc to better represent is planned business activities.

Also on January 27, 2011, the Company authorized a 1:9 reverse stock split decreasing the number of common shares issued and outstanding from 223,300,000 to 24,811,111.

On March 25, 2011, Mr. Robert G. Cormier resigned as Chief Operating Officer and director of the Corporation to pursue other interests.

On March 27, 2011. The Corporation entered into a Memorandum of Agreement with Grid Cloud Solutions Inc (Pink: GRDC) to offer services for carbon accounting and trading for the clients of Grid Cloud Solutions Inc. Grid Cloud Solutions offers energy saving management service to various industrial and commercial clients. Under the Agreement the Corporation will offer carbon services to the clients of Grid Cloud Solutions Inc in exchange for 50% of the revenues generated.

On March 29, 2011, the Corporation revised stock options granted to Mr. John Wilkes, Mr. Robert G Cormier and Mr. Luc C Duchesne, as directors and officers of the Corporation

Your last point is false. James Cao is the CEO of Hemcare and John Wilkes is the CFO.
You can look at the filing here. Scroll to the bottom.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=10875242-1187-40118&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcompanyid%253d766916

Hemmcare just went into a deal with ultroid and issued shares to them. Ultroid CEO is Michael Cao.
Heres the two ceo profiles.

Michael Cao http://www.ultroid.com/team/
James Cao. http://www.4-traders.com/business-leaders/Cao-James-0FK083-E/biography/

You should just do some due dilengence. I know its hard. Heres the filings for hemcare. http://yahoo.brand.edgar-online.com/default.aspx?companyid=766916

These are for Groc. http://www.otcmarkets.com/stock/GROC/filings

This is just two deals.

[asdfu099]

OH MY GOD!!!! You mean Trahan, Baldwin were part of another company? Even Wilkes was? OH MY GOD!

Not sure who the Cao's are and why I should care if they are father and son or brothers. They are not involved in this company.

[ATCrunch]

Bad conflict of interest going on here.

doing business with a relative I see? James Cao and Michael Cao?
http://www.bloomberg.com/research/stocks/people/person.asp?personId=289021192&ticker=HCRE

and Michael Cao
http://www.ultroid.com/team/

On May 19, 2015 the Company licensed perpetual rights to use Ultroid Marketing Development Corp’s products and the trade name “Ultroid System”. The rights will allow the Company to enter into the clinical treatment of Hemorrhoidal Maladies. Amongst several other attributes, the Products are non-invasive and provide fast and effective relief in the treatment of Hemorrhoids. In consideration for the assignment of these rights, the Company prepaid Ultroid Marketing Development Corp., the Licensor $100,000 for an initial order of forty (40) Ultroid Hemorrhoid Management Systems. The prepayment was satisfied in the form of equivalent value of Series A 12% preferred shares of the Licensee. Said Preferred shares contain conversion privilege into the Company's common stock at a conversion price of $.001 per share.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=10873511-1220-7042&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcik%253d1420368

This isn't the first time this has happened in this stock. These guys just shuffle issued shares between companies and themselves. Been doing it for the last 5 years as far as I can tell.

John Wilkes
http://www.4-traders.com/business-leaders/John-Wilkes-0B6V0H-E/biography/

Dr. Luc C. Duchesne
http://www.4-traders.com/business-leaders/Luc-Duchesne-09SS3S-E/biography/

Martin Baldwin
http://www.4-traders.com/business-leaders/Martin-Baldwin-08BFSH-E/biography/

Gilles A. Trahan
http://www.4-traders.com/business-leaders/Gilles-Trahan-0035D9-E/biography/

This is the history of your company

First Filing where Martin Baldwin and Gilles Trahan buy the company and do business with a company called MSE Environ-Tech Corp(5 million dollar note). Gilles is in control of MSE the website says(conflict of interest?). http://www.mseenviro-tech.com/contact.html
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=6910495-1056-8625&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcompanyid%253d766916

"In November 2009 MSE Enviro-Tech Corp ("MSE") assigned to the Company the rights to sell MSE's fire retardant products in the United States. In consideration for the assignment of these rights, the Company issued MSE a promissory note in the principal amount of $5,000,000.

The note bears interest at 6% per year, is unsecured, and is payable on November 16, 2012. At the option of the holder, the note can be converted into shares of the Company's common stock. The number of shares to be issued will be determined by dividing the amount of the note to be converted by $0.25."


Then the MSE contract goes under and cost a $252K termination fee.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7286072-947-48551&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcompanyid%253d766916
NOTE 10
On May 5, 2010 the Assignment of Contract Rights with MSE Enviro-Tech Corp. (“MEVT”) was terminated resulting in the Company being released from its debt obligation of $5,000,000 as well as relinquishing its rights to the Hartindo and Dectan products. This transaction will be accounted for in the Company’s Financial Statements for the three months ended June 30, 2010. The carrying values of the Intangible Assets – net ($4,884,360) and the Convertible Note Payable and Accrued Interest on Convertible Note Payable ($5,137,261) at May 5, 2010 will be eliminated and a gain on termination of agreement ($252,901) will be recognized

Because of this. bio carbon solutions is born. Luc Duchesne is now CEO and John Wilkes joins the party.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7752047-1075-63114&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcompanyid%253d766916
On January 25, 2011, Mr. Duchesne and Mr. Cormier were appointed directors and officers of the Company and Mr. Wilkes resigned his position of President and CEO of the Company. Mr Wilkes remained as director. Mr. Wilkes was granted options for 1,000,000 common stocks of the company exercisable within two years, exempt of the reverse stock split reported in 5.07.

Now hes playing with old Great rock dev company called Grid cloud solutions before it changed its name
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=7906540-1192-76857&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcompanyid%253d766916

On March 27, 2011 the Corporation entered into a Memorandum of Agreement with Grid Cloud Solutions Inc (Pink: GRDC) to offer services for carbon accounting and trading for the clients of Grid Cloud Solutions Inc. Grid Cloud Solutions offers energy saving management service to various industrial and commercial clients. Under the Agreement the Corporation will offer carbon services to the clients of Grid Cloud Solutions Inc in exchange for 50% of the revenues generated. This introduction was generated by Dr Duchesne who is also a director and officer of Grid Cloud Solutions Inc. There is no direct benefit to Dr Duchesne for this introduction. No additional compensation was granted to Dr Duchesne

Did a ceo switch by here and a reverse split. Wilkes is down to cfo. Hired James Cao so he could do business with Ultroid. Also changing the name soon from NSU Resources Inc to Hemcare
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=10576358-1186-7148&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcompanyid%253d766916

Last filing showing more conflict of interest.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=10873511-1220-7042&type=sect&TabIndex=2&companyid=766916&ppu=%252fdefault.aspx%253fcompanyid%253d766916

On May 19, 2015 the Company licensed perpetual rights to use Ultroid Marketing Development Corp’s products and the trade name “Ultroid System”. The rights will allow the Company to enter into the clinical treatment of Hemorrhoidal Maladies. Amongst several other attributes, the Products are non-invasive and provide fast and effective relief in the treatment of Hemorrhoids. In consideration for the assignment of these rights, the Company prepaid Ultroid Marketing Development Corp., the Licensor $100,000 for an initial order of forty (40) Ultroid Hemorrhoid Management Systems. The prepayment was satisfied in the form of equivalent value of Series A 12% preferred shares of the Licensee. Said Preferred shares contain conversion privilege into the Company's common stock at a conversion price of $.001 per share.


Here is all the filings. I suggest you take a look at these
http://yahoo.brand.edgar-online.com/default.aspx?companyid=766916
and Great rock.
http://www.otcmarkets.com/financialReportViewer?symbol=GROC&id=41679
http://www.otcmarkets.com/stock/GROC/filings

[funnyG986]

HCRE very good news indeed

[startingboy]

this will be a monster! HemCare Health Services to Acquire Access to National Insurance Providers through Strategic Acquisition

TAMPA, Fla., Sep. 3, 2015 /PRNewswire/ -- HemCare Health Services, Inc. (OTC; HCRE) – HemCare Health Services has signed a binding letter of intent to acquire 95% of John Isaac Delgado, M.D., P.A.

The acquisition will provide HemCare with access to over 200 insurance agreements from various national PPO and HMO insurance providers. The concept is referred to as a single member EIN, and is very common with large multi-location medical offices.

HemCare's CEO James Cao commented "Many insurance providers no longer offer open registration to new medical clinics. This purchase will permit every new HemCare clinic opened in the United States the ability to immediately accept and bill those insurance providers for services rendered. This is accomplished through a Management Services Organization agreement with each new HemCare franchise location."

On May 19, 2015 the Company announced it had licensed the perpetual rights to use Ultroid Marketing Development Corp's products and the trade name "Ultroid System". The rights will allow the Company to enter into a clinical treatment of Hemorrhoidal Maladies. Amongst several other attributes, the Products are non-invasive and provide fast and effective relief in the treatment of Hemorrhoids.

HemCare will acquire the controlling interest through the issuance of 2,000,000 restricted common shares. Management expects to conclude the acquisition following due diligence and an audit of the business.

About HemCare

HemCare Health Services, Inc. (HCRE) is a public health care and technology company. The company's mission is to become an integrated provider of systems to treat and cure Hemorrhoidal Disease through franchising a successful clinical model and use of proprietary devices.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publically update or revise any forward-looking statement.

Contact: James Cao, President, [phone]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hemcare-health-services-to-acquire-access-to-national-insurance-providers-through-strategic-acquisition-300137511.html

SOURCE HemCare Health Services, Inc.

[skipsvalue]

Link to press release
http://finance.yahoo.com/news/hemcare-health-services-acquire-access-123000280.html

[skipsvalue]

Press out at 8:30

[threewheeler]

10Q http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10875242

[skipsvalue]

These are very important milestones for the Company I will be posting updated corporate information as the moderator for HCRE. This will be a fun ride get on board

[startingboy]

looks like 1.00+ coming, August 19 Item 1.01 Entry into a Material Definitive Agreement

On May 19, 2015 the Company licensed perpetual rights to use Ultroid Marketing Development Corp’s products and the trade name “Ultroid System”. The rights will allow the Company to enter into the clinical treatment of Hemorrhoidal Maladies. Amongst several other attributes, the Products are non-invasive and provide fast and effective relief in the treatment of Hemorrhoids. In consideration for the assignment of these rights, the Company prepaid Ultroid Marketing Development Corp., the Licensor $100,000 for an initial order of forty (40) Ultroid Hemorrhoid Management Systems. The prepayment was satisfied in the form of equivalent value of Series A 12% preferred shares of the Licensee. Said Preferred shares contain conversion privilege into the Company's common stock at a conversion price of $.001 per share.

The license rights will permit the Company to diversify its current business opportunities. More particularly, it will allow the Company to set up clinics and establish an International Brand. While the Company is impressed with the market potential of the Ultroid System, there can be no assurance of its success and market acceptance on a domestic or international basis.

Related to the License above, The Company had entered into a contingent Consulting Agreement with AIM International Associates Ltd. (“Consultant”) whereby the Consultant would, in the event of a successful acquisition of the license described above, be compensated certain compensation. Now that the Company has secured the rights to the Ultroid System, the Consulting Agreement compensation is due and payable.

Consultant has been compensated a $350,000 fee payable by a promissory note of the same amount bearing 9% interest compounded annually payable within 18 months of execution. Until the repayment in full of the promissory note, Consultant will receive $3,000 of each new franchise fee and 1.5% of royalties collected by the Company from the franchisee on treatments and products' services. After the payment of the note, a 3% royalty on all services, licenses and fees will be paid for an additional 10 years.

Item 5.01 Change of Control

On May 21, 2015 the Company issued 100,000,000 common shares to the Licensor pursuant to the conversion notice from the Licensor shareholders. The shares were issued under an exemption from registration and are restricted shares as the term defines. The issuance has caused a change in control. Mr. Jaswinder Singh now holds 50,000,000 shares of the Company’s common stock representing 39 % and, also on the same day, Mr. Tom Krutulis also converted into 50,000,000 common shares representing 39% of the Company’s Common stock. Mr. Singh and Mr. Krutulis, the two shareholders have effectively become the controlling shareholders of the Company.

Item 8.01 Other Events

On May 22, 2015 seven other holders of Preferred Series A shares converted to common shares resulting in the issuance of a total of 38,300,000 common shares issued.

The Company has a new address at 4830 W. Kennedy Blvd., Suite 60, Tampa, FL., 33609. It has changed its telephone number to (844) 4 HEMCARE, (844) 4-436-2273.


2


SIGNATURE(S)

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.



Hemcare Health Services Inc.


Date: August 19, 2015 By: /s/ James Cao


Name:
James Cao


Title:
President and Chief Executive Officer

[startingboy]

https://piles-relief.com/information-for-doctors/

[skipsvalue]

Load up good things coming very soon
Just sayin

[startingboy]

the only FDA approved device to treat and cure all hemorrhoids grades 1 through 4

this could be massive :)

[skipsvalue]

Get ready
Just sayin

[skipsvalue]

With the new franchises being signed over the next few weeks I am confident the company will generate over 10 million in revenue over the next year

[threewheeler]

ok got my starter locked up, bring on dollarland HCRE

[skipsvalue]

There are a few doctors in the tampa bay area I know that are buying franchise that will add over 2mill in revenue over the next year

[Mac-A-Million]

What's happening? NEWS? Why is it gonna move?

[skipsvalue]

The run to $1.00 getting started

[skipsvalue]

Scared market makets trying to make it look bad, with news to be coming soon on doctors signing up for the franchise this thing will fly

[threewheeler]

whacker to start

[skipsvalue]

I feel a great week ahead

[threewheeler]

HCRE .80 close dam nice

[threewheeler]

yea I hit a couple generic boards today HCRE

[skipsvalue]

The spread is the cause if people just keep buying the ask it will be over $1 in no time I only see 2000 shares at .80 then its a buck. Spread the word this is a low float that could have a big run

[threewheeler]

nice don't know why we had to go back to .10 lousy traders

[skipsvalue]

With the number of doctors they are signing up this will be $5+ a share

[threewheeler]

HCRE looks to be headed into dollar land

[skipsvalue]

Fireworks this weekend

[skipsvalue]

Big new coming next week doctors are loving this

[threewheeler]

next ask slap 1.00 HCRE

[startingboy]

http://www.ultroid.com/, https://piles-relief.com/ ,

http://webtalkradio.net/internet-talk-radio/2015/03/23/healthy-strong-and-active-your-strategy-for-life-interview-michael-knox-ceo-vascular-technologies-inc-ultroid-painless-treatment-for-hemorrhoids/

http://www.zoominfo.com/p/Michael-Cao/471120

[startingboy]

did you see this 8k looks huge to me ?

Item 1.01 Entry into a Material Definitive Agreement

On May 19, 2015 the Company licensed perpetual exclusive rights to use Ultroid Marketing Development Corp.s products and the trade name “Ultroid System”. The rights will allow the Company to enter into the clinical treatment of Hemorrhoidal Maladies. Amongst several other attributes, the Products are non-invasive and provide fast and effective relief in the treatment of Hemorrhoids. In consideration for the assignment of these rights, the Company prepaid Ultroid Marketing Development Corp., the Licensor $100,000 for an initial order of forty (40) Ultroid Hemorrhoid Management Systems. The prepayment was satisfied in the form of equivalent value of Series A 12% preferred shares of the Licensee. Said Preferred shares contain conversion privilege into the Company's common stock at a conversion price of $.001 per share.

The license rights will permit the Company to diversify its current business opportunities. More particularly, it will allow the Company to set up clinics and establish an International Brand. While the Company is impressed with the market potential of the Ultroid System, there can be no assurance of its success and market acceptance on a domestic or international basis.

Related to the License above, The Company had entered into a contingent Consulting Agreement with AIM International Associates Ltd. (“Consultant”) whereby the Consultant would, in the event of a successful acquisition of the license described above, be compensated certain compensation. Now that the Company has secured the rights to the Ultroid System, the Consulting Agreement compensation is due and payable.

Consultant has been compensated a $350,000 fee payable by a promissory note of the same amount bearing 9% interest compounded monthly payable within 18 months of execution. Until the repayment in full of the promissory note, Consultant will receive $3,000 of each new franchise fee and a 3.5% gross royalty on treatments and products' services. After the payment of the note, a 3% royalty on all services, licenses and fees will be paid for an additional 10 years.

Item 5.01 Change of Control

On May 21, 2015 the Company issued 100,000,000 common shares to the Licensor pursuant to the conversion notice from the Licensor shareholders. The shares were issued under an exemption from registration and are restricted shares as the term defines. The issuance has caused a change in control. Mr. Jaswinder Singh now holds 50,000,000 shares of the Company’s common stock representing 39 % and, also on the same day, Mr. Tom Krutulis also converted into 50,000,000 common shares representing 39 % of the Company’s Common stock. Mr. Singh and Mr. Krutulis, the two shareholders have effectively become the controlling shareholders of the Company.

Item 8.01 Other Events

On May 21, 2015 the Company issued 100,000,000 common shares to the Licensor pursuant to the conversion notice from the Licensor shareholders. The shares were issued under an exemption from registration and are restricted shares as the term defines. The issuance has caused a change in control. Mr. Jaswinder Singh now holds 50,000,000 shares of the Company’s common stock representing 39% (after the subsequent conversion below) and, also on the same day, Mr. Tom Krutulis also converted into 50,000,000 common shares representing 39% (after the subsequent conversion below) of the Company’s Common stock. Mr. Singh and Mr. Krutulis, the two shareholders have effectively become the controlling shareholders of the Company.

On May 22, 2015 four other holders of Preferred Series A shares converted to common shares resulting in the issuance of a total of 24,830,000 common shares issued.




http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10721191

[skipsvalue]

Im hearing some deals with doctors to be anouced
Just sayin